Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies.

IF 2.7 3区医学 Q2 PSYCHOLOGY, CLINICAL

American Journal of Drug and Alcohol Abuse Pub Date : 2024-01-02 Epub Date: 2024-01-12 DOI:10.1080/00952990.2023.2292010

Samantha Johnstone, Maryam Sorkhou, Molly Zhang, Sarah S Dermody, Rachel A Rabin, Tony P George

引用次数: 0

Abstract

Clinical trial name: Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in SchizophreniaURL: www.clinicaltrials.gov; Registration Number: NCT03189810.

查看原文本刊更多论文

大麻渴求预测精神分裂症患者吸烟情况：对两项大麻戒断研究的二次分析。

临床试验名称：重复经颅磁刺激（rTMS）对精神分裂症患者大麻使用和认知结果的影响URL：www.clinicaltrials.gov；注册号：NCT03189810：NCT03189810。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Drug and Alcohol Abuse SUBSTANCE ABUSE-

CiteScore

4.70

自引率

3.70%

发文量

期刊介绍： The American Journal of Drug and Alcohol Abuse (AJDAA) is an international journal published six times per year and provides an important and stimulating venue for the exchange of ideas between the researchers working in diverse areas, including public policy, epidemiology, neurobiology, and the treatment of addictive disorders. AJDAA includes a wide range of translational research, covering preclinical and clinical aspects of the field. AJDAA covers these topics with focused data presentations and authoritative reviews of timely developments in our field. Manuscripts exploring addictions other than substance use disorders are encouraged. Reviews and Perspectives of emerging fields are given priority consideration. Areas of particular interest include: public health policy; novel research methodologies; human and animal pharmacology; human translational studies, including neuroimaging; pharmacological and behavioral treatments; new modalities of care; molecular and family genetic studies; medicinal use of substances traditionally considered substances of abuse.